Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Debaveye

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Endocrinology|February 23, 2008
Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activityBjörn Ellger, Milan C Richir, Paul A M van Leeuwen, et al.
Journal of Bone and Joint Infection|April 6, 2026
Combined analysis of host immune response, biofilm genes, and 16S rRNA detection in fracture-related infection: an observational cohort studyMelissa Depypere, Jonathan Sliepen, Jolien Onsea, et al.
Diagnostic and Prognostic Research|July 21, 2025
A comparison of modeling approaches for static and dynamic prediction of central-line bloodstream infections using electronic health records (part 1): regression modelsShan Gao, Elena Albu, Hein Putter, et al.
Critical Care Medicine|February 27, 2009
Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illnessIlse Vanhorebeek, Björn Ellger, Rita De Vos, et al.
Kidney International|June 19, 2009
Hyperglycemic kidney damage in an animal model of prolonged critical illnessIlse Vanhorebeek, Jan Gunst, Björn Ellger, et al.
Medical Mycology|September 20, 2022
Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic studyRuth Van Daele, Joost Wauters, Omar Elkayal, et al.
Clinical Pharmacokinetics|October 11, 2023
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing StrategiesAnouk M E Jansen, Beatrijs Mertens, Isabel Spriet, et al.
Intensive Care Medicine|September 15, 2018
Adrenocortical function during prolonged critical illness and beyond: a prospective observational studyBram Peeters, Philippe Meersseman, Sarah Vander Perre, et al.
Transplantation|September 30, 2024
Dynamics and Evolution of Donor-derived Cytomegalovirus Infection in 3 Solid Organ Transplant Recipients With the Same Multiorgan DonorFien Horsten, Sunwen Chou, Sarah Gillemot, et al.
Critical Care (London, England)|September 15, 2009
Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illnessLiese Mebis, Yves Debaveye, Björn Ellger, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Endocrinology|February 23, 2008
Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activityBjörn Ellger, Milan C Richir, Paul A M van Leeuwen, et al.
Journal of Bone and Joint Infection|April 6, 2026
Combined analysis of host immune response, biofilm genes, and 16S rRNA detection in fracture-related infection: an observational cohort studyMelissa Depypere, Jonathan Sliepen, Jolien Onsea, et al.
Diagnostic and Prognostic Research|July 21, 2025
A comparison of modeling approaches for static and dynamic prediction of central-line bloodstream infections using electronic health records (part 1): regression modelsShan Gao, Elena Albu, Hein Putter, et al.
Critical Care Medicine|February 27, 2009
Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illnessIlse Vanhorebeek, Björn Ellger, Rita De Vos, et al.
Kidney International|June 19, 2009
Hyperglycemic kidney damage in an animal model of prolonged critical illnessIlse Vanhorebeek, Jan Gunst, Björn Ellger, et al.
Medical Mycology|September 20, 2022
Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic studyRuth Van Daele, Joost Wauters, Omar Elkayal, et al.
Clinical Pharmacokinetics|October 11, 2023
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing StrategiesAnouk M E Jansen, Beatrijs Mertens, Isabel Spriet, et al.
Intensive Care Medicine|September 15, 2018
Adrenocortical function during prolonged critical illness and beyond: a prospective observational studyBram Peeters, Philippe Meersseman, Sarah Vander Perre, et al.
Transplantation|September 30, 2024
Dynamics and Evolution of Donor-derived Cytomegalovirus Infection in 3 Solid Organ Transplant Recipients With the Same Multiorgan DonorFien Horsten, Sunwen Chou, Sarah Gillemot, et al.
Critical Care (London, England)|September 15, 2009
Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illnessLiese Mebis, Yves Debaveye, Björn Ellger, et al.
Pageof 11